-
1
-
-
0026669469
-
p53 Function and dysfunction
-
Vogelstein B and Kinzler KW. p53 Function and dysfunction. Cell (1992) 70: 523-526.
-
(1992)
Cell
, vol.70
, pp. 523-526
-
-
Vogelstein, B.1
Kinzler, K.W.2
-
2
-
-
0029845760
-
Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies
-
Harris CC. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J. Natl. Cancer Inst. (1996) 88: 1442-1455.
-
(1996)
J. Natl. Cancer Inst.
, vol.88
, pp. 1442-1455
-
-
Harris, C.C.1
-
3
-
-
0031802921
-
Keeping an old friend under control: Regulation of p53 stability
-
Kubbutat MH and Vousden KH. Keeping an old friend under control: regulation of p53 stability. Mol. Med. Today (1998) 4: 250-256.
-
(1998)
Mol. Med. Today
, vol.4
, pp. 250-256
-
-
Kubbutat, M.H.1
Vousden, K.H.2
-
4
-
-
33746627694
-
Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity
-
Leonard K, Marugan JJ, Raboisson P, Calvo R, Gushue JM, Koblish HK, Lattanze J, Zhao S, Cummings MD, Player MR, Maroney AC and Lu T. Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activity. Bioorg. Med Chem. Lett. (2006) 16: 3463-3468.
-
(2006)
Bioorg. Med Chem. Lett.
, vol.16
, pp. 3463-3468
-
-
Leonard, K.1
Marugan, J.J.2
Raboisson, P.3
Calvo, R.4
Gushue, J.M.5
Koblish, H.K.6
Lattanze, J.7
Zhao, S.8
Cummings, M.D.9
Player, M.R.10
Maroney, A.C.11
Lu, T.12
-
5
-
-
0037317840
-
Inhibiting the p53-MDM2 interaction: An important target for cancer therapy
-
Chene P. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat. Rev. Cancer (2003) 3: 102-109.
-
(2003)
Nat. Rev. Cancer
, vol.3
, pp. 102-109
-
-
Chene, P.1
-
6
-
-
0032566066
-
The proliferation of normal human fibroblasts is dependent upon negative regulation of p53 function by mdm2
-
Blaydes JP and Wynford-Thomas D. The proliferation of normal human fibroblasts is dependent upon negative regulation of p53 function by mdm2. Oncogene (1998) 16: 3317-3322.
-
(1998)
Oncogene
, vol.16
, pp. 3317-3322
-
-
Blaydes, J.P.1
Wynford-Thomas, D.2
-
7
-
-
0034716943
-
A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines
-
Chène P, Fuchs J, Bohn J, GarcIa-EcheverrIa C, Furet P and Fabbro D. A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines. J. Mol. Biol. (2000) 299: 245-253.
-
(2000)
J. Mol. Biol.
, vol.299
, pp. 245-253
-
-
Chène, P.1
Fuchs, J.2
Bohn, J.3
GarcIa-EcheverrIa, C.4
Furet, P.5
Fabbro, D.6
-
8
-
-
0031282325
-
Design of a synthetic Mdm2-binding mini protein that activates the p53 response in-vivo
-
Bottger A, Bottger V, Sparks A, Liu WL, Howard SF and Lane DP. Design of a synthetic Mdm2-binding mini protein that activates the p53 response in-vivo. Curr. Biol. (1997) 7: 860-869.
-
(1997)
Curr. Biol.
, vol.7
, pp. 860-869
-
-
Bottger, A.1
Bottger, V.2
Sparks, A.3
Liu, W.L.4
Howard, S.F.5
Lane, D.P.6
-
9
-
-
0033580435
-
Cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
-
Wasylyk C, Salvi R, Argentini M, Dureuil C, Delumeau I, Abecassis J, Debussche L and Wasylyk B. cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53. Oncogene (1999) 18: 1921-1934.
-
(1999)
Oncogene
, vol.18
, pp. 1921-1934
-
-
Wasylyk, C.1
Salvi, R.2
Argentini, M.3
Dureuil, C.4
Delumeau, I.5
Abecassis, J.6
Debussche, L.7
Wasylyk, B.8
-
10
-
-
0035186743
-
Oligonucleotides as a novel therapeutic approach to human breast cancer: In-vitro and in-vivo activities and mechanisms
-
Wang H, Nan L, Yu D, Agrawal S and Zhang R. oligonucleotides as a novel therapeutic approach to human breast cancer: In-vitro and in-vivo activities and mechanisms. Clin. Cancer Res. (2001) 7: 3613-3624.
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 3613-3624
-
-
Wang, H.1
Nan, L.2
Yu, D.3
Agrawal, S.4
Zhang, R.5
-
11
-
-
13944274061
-
Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells
-
Grasberger BL, Lu T, Schubert C, Parks DJ, Carver TE, Koblish HK, Cummings MD, LaFrance LV, Milkiewicz KL, Calvo RR, Maguire D, Lattanze J, Franks CF, Zhao S, Ramachandren K, Bylebyl GR, Zhang M, Manthey CL, Petrella EC, Pantoliano MW, Deckman IC, Spurlino JC, Maroney AC, Tomczuk BE, Molloy CJ and Bone RF. Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells. J. Med. Chem. (2005) 48: 909-912.
-
(2005)
J. Med. Chem.
, vol.48
, pp. 909-912
-
-
Grasberger, B.L.1
Lu, T.2
Schubert, C.3
Parks, D.J.4
Carver, T.E.5
Koblish, H.K.6
Cummings, M.D.7
LaFrance, L.V.8
Milkiewicz, K.L.9
Calvo, R.R.10
Maguire, D.11
Lattanze, J.12
Franks, C.F.13
Zhao, S.14
Ramachandren, K.15
Bylebyl, G.R.16
Zhang, M.17
Manthey, C.L.18
Petrella, E.C.19
Pantoliano, M.W.20
Deckman, I.C.21
Spurlino, J.C.22
Maroney, A.C.23
Tomczuk, B.E.24
Molloy, C.J.25
Bone, R.F.26
more..
-
12
-
-
0035895350
-
Chalcone derivatives antagonize interactions between the human oncoprotein. MDM2 and p53
-
Stoll R, Renner C, Hansen S, Palme S, Klein C, Belling A, Zeslawski W, Kamionka M, Rehm T, Mühlhahn P, Schumacher R, Hesse F, Kaluza B, Voelter W, Engh RA and Holak TA. Chalcone derivatives antagonize interactions between the human oncoprotein. MDM2 and p53. Biochem. (2000) 40: 336-344.
-
(2000)
Biochem.
, vol.40
, pp. 336-344
-
-
Stoll, R.1
Renner, C.2
Hansen, S.3
Palme, S.4
Klein, C.5
Belling, A.6
Zeslawski, W.7
Kamionka, M.8
Rehm, T.9
Mühlhahn, P.10
Schumacher, R.11
Hesse, F.12
Kaluza, B.13
Voelter, W.14
Engh, R.A.15
Holak, T.A.16
-
13
-
-
0037044103
-
The initial evaluation of non-peptidic small-molecule HDM2 inhibitors based on p53-HDM2 complex structure
-
Zhao J, Wang M, Chen J, Luo A, Wang X, Wu M, Yin D and Liu Z. The initial evaluation of non-peptidic small-molecule HDM2 inhibitors based on p53-HDM2 complex structure. Cancer Let. (2002) 183: 69-77.
-
(2002)
Cancer Let.
, vol.183
, pp. 69-77
-
-
Zhao, J.1
Wang, M.2
Chen, J.3
Luo, A.4
Wang, X.5
Wu, M.6
Yin, D.7
Liu, Z.8
-
14
-
-
3843055877
-
p53-dependent transcription in mdm2-overexpressing cells
-
Galatin PS and Abraham DJ. p53-dependent transcription in mdm2-overexpressing cells. J. Med. Chem. (2004) 47: 4163-4165.
-
(2004)
J. Med. Chem.
, vol.47
, pp. 4163-4165
-
-
Galatin, P.S.1
Abraham, D.J.2
-
15
-
-
19944431512
-
1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: Discovery and SAR
-
Parks DJ, LaFrance LV, Calvo RR, Milkiewicz KL, Gupta V, Lattanze J, Ramachandren K, Carver TE, Petrella EC, Cummings MD, Maguire D, Grasberger BL and Lu T. 1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: Discovery and SAR. Bioorg. Med. Chem. Lett. (2005) 15: 765-770.
-
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, pp. 765-770
-
-
Parks, D.J.1
LaFrance, L.V.2
Calvo, R.R.3
Milkiewicz, K.L.4
Gupta, V.5
Lattanze, J.6
Ramachandren, K.7
Carver, T.E.8
Petrella, E.C.9
Cummings, M.D.10
Maguire, D.11
Grasberger, B.L.12
Lu, T.13
-
16
-
-
0000191614
-
Stochastic algorithms for maximizing molecular diversity
-
Agrafiotis DK. Stochastic algorithms for maximizing molecular diversity. J. Chem. Inf. Comput. Sci. (1997) 37: 841-851.
-
(1997)
J. Chem. Inf. Comput. Sci.
, vol.37
, pp. 841-851
-
-
Agrafiotis, D.K.1
-
17
-
-
0034351492
-
Kolmogorov-Smirnov statistic and its application in library design
-
Rassokhin DN and Agrafiotis DK. Kolmogorov-Smirnov statistic and its application in library design. J. Mol. Graphics Model (2000) 18: 368-382.
-
(2000)
J. Mol. Graphics Model
, vol.18
, pp. 368-382
-
-
Rassokhin, D.N.1
Agrafiotis, D.K.2
-
19
-
-
18244380348
-
High-density miniaturized thermal shift assays as a general strategy for drug discovery
-
Pantoliano MW, Petrella EC, Kwasnoski JD, Lobanov VS, Myslik J, Graf E, Carver T, Asel E, Springer BA, Lane P and Salemme FR. High-density miniaturized thermal shift assays as a general strategy for drug discovery. J. Biomol. (2001) 6: 429-440.
-
(2001)
J. Biomol.
, vol.6
, pp. 429-440
-
-
Pantoliano, M.W.1
Petrella, E.C.2
Kwasnoski, J.D.3
Lobanov, V.S.4
Myslik, J.5
Graf, E.6
Carver, T.7
Asel, E.8
Springer, B.A.9
Lane, P.10
Salemme, F.R.11
-
20
-
-
33645357208
-
Substituted 1,4-benzodiazepine-2,5-diones as alpha-helix mimetic antagonists of the HDM2-p53 protein-protein interaction
-
Cummings MD, Schubert C, Parks DJ, Calvo RR, LaFrance LV, Lattanze J, Milkiewicz KL and Lu T. Substituted 1,4-benzodiazepine-2,5-diones as alpha-helix mimetic antagonists of the HDM2-p53 protein-protein interaction. Chem. Biol. Drug Des. (2006) 67: 201-205.
-
(2006)
Chem. Biol. Drug Des.
, vol.67
, pp. 201-205
-
-
Cummings, M.D.1
Schubert, C.2
Parks, D.J.3
Calvo, R.R.4
LaFrance, L.V.5
Lattanze, J.6
Milkiewicz, K.L.7
Lu, T.8
-
21
-
-
84856304572
-
Structural determinants of benzodiazepinedione/peptide-based p53-HDM2 inhibitors using 3D-QSAR, docking and molecular dynamics
-
DOI: 10.1007/s00894-011-1041-4
-
Wang F, Li Y, Ma Z, Wang X and Wang Y. Structural determinants of benzodiazepinedione/peptide-based p53-HDM2 inhibitors using 3D-QSAR, docking and molecular dynamics. J. Mol. Model. (2011) DOI: 10.1007/s00894-011-1041-4.
-
(2011)
J. Mol. Model.
-
-
Wang, F.1
Li, Y.2
Ma, Z.3
Wang, X.4
Wang, Y.5
-
22
-
-
0035889627
-
The tumor suppressor p53: From structures to drug discovery
-
Galatin PS and Abraham DJ. The tumor suppressor p53: from structures to drug discovery. Proteins (2001) 45: 169-175.
-
(2001)
Proteins
, vol.45
, pp. 169-175
-
-
Galatin, P.S.1
Abraham, D.J.2
-
23
-
-
1542635664
-
Retrospect and prospect of virtual screening in drug lead discovery
-
Xu H and Agrafiotis DK. Retrospect and prospect of virtual screening in drug lead discovery. Curr. Topics Med. Chem. (2002) 2: 1305-1320.
-
(2002)
Curr. Topics Med. Chem.
, vol.2
, pp. 1305-1320
-
-
Xu, H.1
Agrafiotis, D.K.2
-
24
-
-
84865179106
-
-
Accelrys Inc, San Diego
-
Discovery Studio 2.1. Accelrys Inc, San Diego (2007).
-
(2007)
Discovery Studio 2.1
-
-
-
25
-
-
0342645331
-
-
Chemical Computing Group Inc, Montreal
-
MOE Molecular Operating Environment, Chemical Computing Group Inc, Montreal (2008).
-
(2008)
MOE Molecular Operating Environment
-
-
-
26
-
-
84870828756
-
-
SYBYL 8.0, Missouri
-
SYBYL 8.0, Tripos International, Missouri (2008).
-
(2008)
Tripos International
-
-
-
27
-
-
27344459398
-
Virtual computational chemistry laboratory-design and description
-
Tetko IV, Gasteiger J, Todeschini R, Mauri A, Livingstone D, Ertl P, Palyulin VA, Radchenko EV, Zefirov NS, Makarenko AS, Tanchuk VY and Prokopenko VV. Virtual computational chemistry laboratory-design and description. J. Comput. Aid Mol. Des. (2005) 19: 453-463.
-
(2005)
J. Comput. Aid Mol. Des.
, vol.19
, pp. 453-463
-
-
Tetko, I.V.1
Gasteiger, J.2
Todeschini, R.3
Mauri, A.4
Livingstone, D.5
Ertl, P.6
Palyulin, V.A.7
Radchenko, E.V.8
Zefirov, N.S.9
Makarenko, A.S.10
Tanchuk, V.Y.11
Prokopenko, V.V.12
-
28
-
-
77958030331
-
Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors
-
Roy P and Roy K. Docking and 3D-QSAR studies of diverse classes of human aromatase (CYP19) inhibitors. J. Mol. Model. (2010) 16: 1597-1616.
-
(2010)
J. Mol. Model.
, vol.16
, pp. 1597-1616
-
-
Roy, P.1
Roy, K.2
-
29
-
-
78649315841
-
Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors
-
Dai Y, Wang Q, Zhang X, Jia S, Zheng H, Feng D and Yu P. Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors. Eur. J. Med. Chem. (2010) 45: 5612-5620.
-
(2010)
Eur. J. Med. Chem.
, vol.45
, pp. 5612-5620
-
-
Dai, Y.1
Wang, Q.2
Zhang, X.3
Jia, S.4
Zheng, H.5
Feng, D.6
Yu, P.7
-
30
-
-
0028922586
-
LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions
-
Wallace AC, Roman AL and Thornton Janet M. LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Eng. (1995) 8: 127-134.
-
(1995)
Protein Eng.
, vol.8
, pp. 127-134
-
-
Wallace, A.C.1
Roman, A.L.2
Janet, T.M.3
-
31
-
-
33747126523
-
Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein-protein interaction through structure-based drug design
-
Parks DJ, LaFrance LV, Calvo RR, Milkiewicz KL, Marugan JJ, Raboisson P, Schubert C, Koblish HK, Zhao S, Franks CF, Lattanze J, Carver TE, Cummings MD, Maguire D, Grasberger BL, Maroney AC and Lu T. Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein-protein interaction through structure-based drug design. Bioorg. Med. Chem. Lett. (2006) 16: 3310-3314.
-
(2006)
Bioorg. Med. Chem. Lett.
, vol.16
, pp. 3310-3314
-
-
Parks, D.J.1
LaFrance, L.V.2
Calvo, R.R.3
Milkiewicz, K.L.4
Marugan, J.J.5
Raboisson, P.6
Schubert, C.7
Koblish, H.K.8
Zhao, S.9
Franks, C.F.10
Lattanze, J.11
Carver, T.E.12
Cummings, M.D.13
Maguire, D.14
Grasberger, B.L.15
Maroney, A.C.16
Lu, T.17
-
32
-
-
33747115474
-
Enantiomerically pure 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists
-
Marugan JJ, Leonard K, Raboisson P, Gushue JM, Calvo R, Koblish HK, Lattanze J, Zhao S, Cummings MD, Player MR, Schubert C, Maroney AC and Lu T. Enantiomerically pure 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists. Bioorg. Med. Chem. Lett. (2006) 16: 3115-3120.
-
(2006)
Bioorg. Med. Chem. Lett.
, vol.16
, pp. 3115-3120
-
-
Marugan, J.J.1
Leonard, K.2
Raboisson, P.3
Gushue, J.M.4
Calvo, R.5
Koblish, H.K.6
Lattanze, J.7
Zhao, S.8
Cummings, M.D.9
Player, M.R.10
Schubert, C.11
Maroney, A.C.12
Lu, T.13
-
34
-
-
84865195453
-
-
Version 11.0, CambridgeSoft Inc, Cambridge
-
ChemBioOffice Ultra Version 11.0, CambridgeSoft Inc, Cambridge (2008).
-
(2008)
ChemBioOffice Ultra
-
-
-
36
-
-
0343136966
-
Optimization by Simulated Annealing: Quantitative Studies
-
Kirkpatrick S. Optimization by Simulated Annealing: Quantitative Studies. J. Stat. Phy. (1984) 34: 975-986.
-
(1984)
J. Stat. Phy.
, vol.34
, pp. 975-986
-
-
Kirkpatrick, S.1
-
37
-
-
0029970338
-
Optimization in quantitative structure-activity. relationship: An application of genetic neural networks
-
So SS and Karplus M. Optimization in quantitative structure-activity. relationship: an application of genetic neural networks. J. Med. Chem. (1996) 39: 1521-1530.
-
(1996)
J. Med. Chem.
, vol.39
, pp. 1521-1530
-
-
So, S.S.1
Karplus, M.2
-
38
-
-
34250845013
-
Proteometric study of ghrelin receptor function variations upon mutations using amino acid sequence autocorrelation vectors and genetic algorithm-based least square support vector machines
-
Caballero J, Fernández L, Garriga M, Abreu JI, Collina S and Fernández M. Proteometric study of ghrelin receptor function variations upon mutations using amino acid sequence autocorrelation vectors and genetic algorithm-based least square support vector machines. J. Mol. Graphics Model (2007) 26: 166-178.
-
(2007)
J. Mol. Graphics Model
, vol.26
, pp. 166-178
-
-
Caballero, J.1
Fernández, L.2
Garriga, M.3
Abreu, J.I.4
Collina, S.5
Fernández, M.6
-
39
-
-
84865161559
-
-
4.0. Accelrys Software Inc, San Diego
-
Materials Studio Modeling 4.0. Accelrys Software Inc, San Diego (2007).
-
(2007)
Materials Studio Modeling
-
-
-
40
-
-
0002432565
-
Multivariate adaptive regression splines
-
Friedman JH. Multivariate adaptive regression splines. Ann. Statistics (1991) 19: 1-67.
-
(1991)
Ann. Statistics
, vol.19
, pp. 1-67
-
-
Friedman, J.H.1
-
41
-
-
4444221565
-
UCSF Chimera-a visualization system for exploratory research and analysis
-
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC and Ferrin TE. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. (2004) 25: 1605-1612.
-
(2004)
J. Comput. Chem.
, vol.25
, pp. 1605-1612
-
-
Pettersen, E.F.1
Goddard, T.D.2
Huang, C.C.3
Couch, G.S.4
Greenblatt, D.M.5
Meng, E.C.6
Ferrin, T.E.7
-
42
-
-
77956032710
-
Molecular interaction fields and 3d-qsar studies of p53-mdm2 inhibitors suggest additional features of ligand-target interaction
-
Dezi C, Carotti A, Magnani M, Baroni M, Padova A, Cruciani G, Macchiarulo A and Pellicciari R. Molecular interaction fields and 3d-qsar studies of p53-mdm2 inhibitors suggest additional features of ligand-target interaction. J. Chem. Inf. Model (2010) 50: 1451-1465.
-
(2010)
J. Chem. Inf. Model
, vol.50
, pp. 1451-1465
-
-
Dezi, C.1
Carotti, A.2
Magnani, M.3
Baroni, M.4
Padova, A.5
Cruciani, G.6
McChiarulo, A.7
Pellicciari, R.8
|